EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands

Pieter T de Boer, Jan van de Kassteele, Eric R A Vos, Liselotte van Asten, Dave A Dongelmans, Arianne B van Gageldonk-Lafeber, Gerco den Hartog, Agnetha Hofhuis, Fiona van der Klis, Dylan W de Lange, Lenny Stoeldraijer, RIVM COVID‐19 epidemiology and surveillance team und 4 weitere

Influenza and Other Respiratory Viruses · 2023-08 · 17 (8)

DOI: 10.1111/irv.13174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 22.08.2023. Verfasst von Pieter T de Boer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The severity of Severe Acute Respiratory Syndrome Coronavirus 2 infection varies with age and time. Here, we quantify how age‐specific risks of hospitalization, intensive care unit (ICU) admission, and death upon infection changed from February 2020 to June 2021 in the Netherlands.

Methods

A series of large representative serology surveys allowed us to estimate age‐specific numbers of infections in three epidemic periods (late‐February 2020 to mid‐June 2020, mid‐June 2020 to mid‐February 2021, and mid‐February 2021 to late‐June 2021). We accounted for reinfections and breakthrough infections. Severity measures were obtained by combining infection numbers with age‐specific numbers of hospitalization, ICU admission, and excess all‐cause deaths.

Results

There was an accelerating, almost exponential, increase in severity with age in each period. The rate of increase with age was the highest for death and the lowest for hospitalization. In late‐February 2020 to mid‐June 2020, the overall risk of hospitalization upon infection was 1.5% (95% confidence interval [CI] 1.3–1.8%), the risk of ICU admission was 0.36% (95% CI: 0.31–0.42%), and the risk of death was 1.2% (95% CI: 1.0–1.4%). The risk of hospitalization was significantly increased in mid‐June 2020 to mid‐February 2021, while the risk of ICU admission remained stable over time. The risk of death decreased over time, with a significant drop among ≥70‐years‐olds in mid‐February 2021 to late‐June 2021; COVID‐19 vaccination started early January 2021.

Conclusion

Whereas the increase in severity of Severe Acute Respiratory Syndrome Coronavirus 2 with age remained stable, the risk of death upon infection decreased over time. A significant drop in risk of death among elderly coincided with the introduction of COVID‐19 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AgedHumansNetherlandsCOVID-19 VaccinesAge Factors

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2disease severityepidemiologyinfection fatality ratio

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
  • Department of Intensive Care Medicine Amsterdam UMC (location AMC) Amsterdam The Netherlands.
  • Amsterdam Public Health Research Institute Amsterdam The Netherlands.
  • Laboratory of Medical Immunology Radboudumc Nijmegen The Netherlands.
  • Intensive Care, University Medical Center Utrecht University of Utrecht Utrecht The Netherlands.
  • Statistics Netherlands The Hague The Netherlands.

Zitieren

APA

de Boer, P. T., van de Kassteele, J., Vos, E. R. A., van Asten, L., Dongelmans, D. A., van Gageldonk-Lafeber, A. B., den Hartog, G., Hofhuis, A., van der Klis, F., de Lange, D. W., Stoeldraijer, L., RIVM COVID‐19 epidemiology and surveillance team, de Melker, H. E., Geubbels, E., van den Hof, S., & Wallinga, J. (2023). Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands. Influenza and Other Respiratory Viruses, 17(8). https://doi.org/10.1111/irv.13174

Vancouver

de Boer PT, van de Kassteele J, Vos ERA, van Asten L, Dongelmans DA, van Gageldonk-Lafeber AB, et al. Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands. Influenza and Other Respiratory Viruses. 2023;17(8). doi:10.1111/irv.13174

BibTeX
@article{deBoer2023,
  author = {de Boer, Pieter T and van de Kassteele, Jan and Vos, Eric R A and van Asten, Liselotte and Dongelmans, Dave A and van Gageldonk-Lafeber, Arianne B and den Hartog, Gerco and Hofhuis, Agnetha and van der Klis, Fiona and de Lange, Dylan W and Stoeldraijer, Lenny and RIVM COVID‐19 epidemiology and surveillance team, RIVM COVID‐19 epidemiology and surveillance team and de Melker, Hester E and Geubbels, Eveline and van den Hof, Susan and Wallinga, Jacco},
  title = {Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  volume = {17},
  number = {8},
  doi = {10.1111/irv.13174}
}
Kostenlos starten →